Skip to main content
. 2022 Nov 28;22:1221. doi: 10.1186/s12885-022-10328-6

Fig. 2.

Fig. 2

A summary of molecular subgrouping by the NanoString assay and IHC of 101 patients with gene panel sequencing and clinical characteristics. IHC, Immunohistochemistry; WNT, Wingless signaling-activated; SHH, Sonic-hedgehog signaling-activated; NA, Not available. * ‘Unclassifiable’ in gene panel sequencing indicates absence of subgroup-defining genetic alterations such as mutations in CTNNB1 or SUFU gene